CDMO Archives

Process intensification: Fueling biopharma success at warp speed

Learn about process intensification in biopharma, key strategies for success, and solutions to overcome manufacturing challenges.

December 3, 2024 - 5 minutesmins - By Will Chu

Advanced mass spectrometry turns manufacturing risk into success

Pink crisis, clear solution: how advanced mass spectrometry turned a manufacturing risk into success

Learn how KBI Biopharma used advanced mass spectrometry to address a cell culture media issue and prevent a potential manufacturing disruption.

September 24, 2024 - 6 minutesmins - By External Contributor

The crucial role of rapid toxicology material delivery

Accelerating the path to clinical filing applications with rapid toxicology material delivery

Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials.

September 10, 2024 - 8 minutesmins - By Alexander Burik

News and Trends 28 Aug 2024

GLP-1 shortage: Can biotech companies keep up with rising demand?

How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question.

August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

Expert Advice 19 Jul 2024

The ABC of biotech partnerships

Discover eight different types of biotech partnerships, including what each one entails and its advantages and disadvantages.

July 19, 2024 - 11 minutesmins - By Willow Shah-Neville

KBI Biopharma microbial CLD 16JUL2024 article labiotech main illustration

How a microbial expression update is driving biotech innovation

Discover how microbial expression systems are revolutionizing protein production for next-gen therapies like antibodies and peptides.

July 16, 2024 - 7 minutesmins - By Ute Boronowsky

CDMO industry post BIOSECURE Act: Indian CDMOs take WuXi's place

More News! 11 Jul 2024

CDMO trends post-Wuxi’s exit from the US: who will take its place?

The BIOSECURE Act is reshuffling the deck and Indian CDMOs are looking good. Discover the trends in this evolving landscape.

July 11, 2024 - 8 minutesmins - By Jules Adam

Powering up biologics development using mammalian cell lines

Explore how mammalian cell lines drive biopharmaceutical innovation, acting as mini-factories for vital biotherapeutics and vaccines.

May 21, 2024 - 6 minutesmins - By Sudha Sundaram

News and Trends 18 Apr 2024

Biotech under surveillance: The global impact of the WuXi AppTec controversy

Delve into the ongoing controversy involving the Chinese company WuXi AppTec and the possible impact on U.S. national security measures.

April 18, 2024 - 9 minutesmins - By Jules Adam

Expert Advice 5 Apr 2024

How to build a career as an investigator at the FDA?

Discover the role and implications of an FDA investigator, a career of high responsibility and challenges, from qualifications to application.

April 5, 2024 - 7 minutesmins - By Jules Adam

In Depth 27 Feb 2024

Can the Novo Holdings-Catalent deal set a new standard for Pharma M&A?

Explore the strategic implications of Novo Nordisk’s $16.5B Catalent acquisition on drug supply and market competition.

February 27, 2024 - 7 minutesmins - By Jules Adam

Why Fina Biosolutions partnered with Scorpius BioManufacturing for cGMP production of EcoCRM® (CRM197)

Explore Fina Biosolutions’ alliance with Scorpius BioManufacturing, driving affordability in global conjugate vaccine production.

January 30, 2024 - 5 minutesmins - By External Contributor

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

CDMO

Process intensification: Fueling biopharma success at warp speed

Pink crisis, clear solution: how advanced mass spectrometry turned a manufacturing risk into success

Accelerating the path to clinical filing applications with rapid toxicology material delivery

GLP-1 shortage: Can biotech companies keep up with rising demand?

The ABC of biotech partnerships

How a microbial expression update is driving biotech innovation

CDMO trends post-Wuxi’s exit from the US: who will take its place?

Powering up biologics development using mammalian cell lines

Biotech under surveillance: The global impact of the WuXi AppTec controversy

How to build a career as an investigator at the FDA?

Can the Novo Holdings-Catalent deal set a new standard for Pharma M&A?

Why Fina Biosolutions partnered with Scorpius BioManufacturing for cGMP production of EcoCRM® (CRM197)

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!